|
|
Volumn 334, Issue 4, 1996, Pages 246-254
|
|
Octreotide
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BROMOCRIPTINE;
OCTREOTIDE;
RECEPTOR SUBTYPE;
SOMATOMEDIN;
SOMATOSTATIN RECEPTOR;
ABDOMINAL CRAMP;
ACROMEGALY;
ADENOCARCINOMA;
CARCINOID;
CHOLESTEROL STONE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CORTICOTROPIN RELEASE;
DRUG INDICATION;
ESOPHAGUS VARICES BLEEDING;
FLATULENCE;
GLUCAGON RELEASE;
GLUCOSE INTOLERANCE;
GROWTH HORMONE BLOOD LEVEL;
GROWTH HORMONE RELEASE;
HORMONE ACTION;
HUMAN;
HYPOPHYSIS ADENOMA;
INSULIN RELEASE;
INTESTINE TRANSIT TIME;
INTRAVENOUS DRUG ADMINISTRATION;
MALABSORPTION;
NAUSEA;
PANCREAS FISTULA;
PRIORITY JOURNAL;
RECEPTOR AFFINITY;
RECEPTOR BINDING;
REVIEW;
SUBCUTANEOUS DRUG ADMINISTRATION;
THYROTROPIN RELEASE;
ACROMEGALY;
ADENOMA;
ANTINEOPLASTIC AGENTS, HORMONAL;
CARCINOID TUMOR;
GASTROINTESTINAL AGENTS;
GASTROINTESTINAL DISEASES;
HUMANS;
NEOPLASMS;
OCTREOTIDE;
PANCREATIC DISEASES;
PITUITARY NEOPLASMS;
RECEPTORS, SOMATOSTATIN;
SOMATOSTATIN;
|
|
EID: 0030054029
PISSN: 00284793
EISSN: None
Source Type: Journal
DOI: 10.1056/NEJM199601253340408 Document Type: Review |
|
Times cited : (896)
|
|
References (0)
|
